NIAID signs multimillion-dollar deal with ATCC

By The Science Advisory Board staff writers

November 23, 2021 -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health, awarded a seven-year contract valued at up to $545 million to ATCC to aid NIAID's research efforts in infectious and allergic diseases.

Under the indefinite delivery/indefinite quality contract, ATCC will support NIAID's Division of Clinical Research, Division of Intramural Research, and the Vaccine Research Center by providing rapid response capabilities to infectious diseases, such as COVID-19, as well as services, like assay development and vaccine production.

ATCC is a biological materials and information resource and standards organization, as well as a developer and supplier of authenticated cell lines and microorganisms.

Copyright © 2021

MemberID or email address:  

Forgot your password?